Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Adalimumab evaluated as a treatment for hidradenitis suppurativa in phase II trial

Oct. 5, 2012

First data on once-weekly DPP IV inhibitor MK-3102 reported

Oct. 4, 2012

Eravacycline compared to ertapenem in patients with intra-abdominal infections

Oct. 4, 2012

Ipragliflozin has beneficial effects in Japanese patients with type 2 diabetes

Oct. 4, 2012

PolyMedix presents new antimicrobials against biowarfare pathogens

Oct. 4, 2012

Intravenous dosing of GSK-322 investigated in healthy subjects

Oct. 4, 2012

Delamanid can be administered with efavirenz

Oct. 3, 2012

PAC-14028 evaluated as a treatment for pruritus

Oct. 3, 2012

Seachaid Pharmaceuticals compounds active against Gram-positive bacteria

Oct. 3, 2012

Xention identifies novel ion channel blockers for atrial fibrillation

Oct. 3, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026